BSX : Analysis & Opinions

  1. Merit Medical Hits 52-Week High on Product Pipeline Strength ...

    December 19, 2014
    Strong third-quarter results, a string of FDA approvals for its new products along with a robust product pipeline, all contribute ...
  2. AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst ...

    December 18, 2014
    Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
  3. CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst ...

    December 17, 2014
    CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues ...
  4. Boston Scientific's Chronic Pain Cure Solution Tests Positive ...

    December 16, 2014
    The study results are indicative of the fact that Boston Scientific's (BSX) next-generation Precision Spectra SCS System ...
  5. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  6. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  7. Wednesday IPO Review & Sneak-Peek For Thursday, April 17

    April 17, 2014
    Three IPOs hit exchange floors Wednesday, Moelis & Co (NYSE: TRIV). Trading opened with mixed results, seeing Moelis ...
  8. MedTech Industry Stock Update - Jan 2014 - Industry Outlook

    January 7, 2014
    MedTech Industry Stock Update - Jan 2014 - Industry Outlook
  9. Bear of the Day: Edwards Lifesciences (EW) - Bear of the Day

    December 31, 2013
    Bear of the Day: Edwards Lifesciences (EW) - Bear of the Day
  10. Medtronic Marking Time

    August 20, 2013
    Medtronic looks stuck in low-growth mode for now, but the shares look undervalued.
  11. Where Do The Bears Go Next With St. Jude Medical?

    July 18, 2013
    St. Jude continues to defy bearish expectations of major share loss, but the shares aren't exactly cheap today.
  12. Abbott Adds Two Promising Products

    July 15, 2013
    Abbott makes two solid growth acquisitions that should address large markets.
  13. Broad Weakness Makes It Harder To Like St. Jude Today

    April 18, 2013
    Although I do believe the long-term expectations for St. Jude are increasingly beatable, this could be a frustrating stock ...
  14. Earnings Preview: Medtronic - Analyst Blog

    February 15, 2013
    Leading medical devices company Medtronic (MDT) is scheduled to report its first quarter fiscal 2013 results before the market ...
  15. Milestone for St. Jude's Heart Implant - Analyst Blog

    February 8, 2013
    Medical devices major St. Jude Medical Inc. (STJ) has reached yet another important clinical landmark by registering the ...
  16. ANGO Beats on EPS, Tweaks View - Analyst Blog

    January 4, 2013
    AngioDynamics Inc. (ANGO) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ended November ...
  17. Medtronic's Growth Looks Good, But Can It Last?

    November 22, 2012
    Medtronic may not be a super grower anymore, but it's doing better than the Street seems to acknowledge
  18. AngioDynamics Wins GPO Contract - Analyst Blog

    October 11, 2012
    Therapeutic and diagnostic devices maker AngioDynamics (ANGO) recently won a contract with HealthTrust Purchasing Group, ...
  19. St. Jude Reveals MediGuide - Analyst Blog

    October 10, 2012
    Medical devices major, St. Jude Medical, Inc. (STJ) recently launched its revolutionary MediGuide technology, a three dimensional ...
  20. For Jabil, The Price Is Right, But The Timing Is Uncertain

    September 27, 2012
    Jabil's value looks appealing, but the end markets are shaky and the industry is brutal. If investors believe in the new ...
  21. STJ's Eon Family Wins CE Mark - Analyst Blog

    September 24, 2012
    Medical devices major, St. Jude Medical, Inc. (STJ) recently won European CE Mark approval for its Eon family of neurostimulators ...
  22. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally. ...
  23. St. Jude's Riata Woes Continue - Analyst Blog

    August 21, 2012
    Recently, the U.S. Food and Drug Administration (FDA) agency instructed medical devices major, St. Jude Medical, Inc. (STJ) ...
  24. Medtronic Meets EPS - Analyst Blog

    August 21, 2012
    Medtronic Inc. (MDT) reported first quarter fiscal 2013 earnings per share of 83 cents, up 8% year over year. After taking ...
  25. Earnings Preview: EW - Analyst Blog

    July 23, 2012
    Edwards Lifesciences Corporation (EW) is scheduled to release its second quarter fiscal 2012 results on Tuesday, July 24, ...
  26. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  27. Abbott Labs Dividing Its Growth And Income Potential

    January 26, 2012
    With the coming split of operations, Abbott Labs investors will better be able to choose between growth and income.
  28. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  29. Endo And Forest – Dumpster-Diving In Pharma

    September 21, 2011
    Endo and Forest have problems; however, the valuations seem excessively low.
  30. Medtronic's Healthy Growth Outlook

    August 29, 2011
    Medtronic's stock deserves a close look.
  31. The Perpetual Boston Scientific Turnaround Story

    August 4, 2011
    Another quarter brings another hope for better days at BSX.
  32. Better Budgets, Better Times For Robots

    July 12, 2011
    With healthier budgets at hospitals, robots are looking better and better.
  33. Johnson & Johnson Surrenders In Stents

    June 17, 2011
    JNJ makes a tough and surprising, but ultimately wise, decision.
  34. Despite The Noise, Abbott Still A Value

    April 25, 2011
    Abbott has made some curious moves of late, but the value is still there.
  35. Can St. Jude Live Up To Newfound Expectations?

    April 25, 2011
    St. Jude faces something it has rarely seen in the past - high expectations.
  36. Medtronic's Midlife Crisis

    February 24, 2011
    Medtronic lacks growth, but quality is still in place.
  37. Multiple Value Creation Opportunities For Stryker

    February 2, 2011
    Stryker could end up being acquired by a larger rival, but company growth trends remain appealingly robust in their own right. ...
  38. 2010: The Year In Med-Tech Deals

    December 29, 2010
    2010 was a relatively slow year for deals in the med-tech sector.
  39. Hottest Device Stocks Of 2010

    December 28, 2010
    The year's top performers in a tough medical device sector.
  40. Cooper: A Growing Play On Eye Care

    December 10, 2010
    Cooper is continuting to grow very well in a tough healthcare market, and shows signs of a shining future.
  41. Stryker Moves On From A Long Mistake

    December 8, 2010
    Stryker finally rids itself of a long-failed product. Find out if this othopedic devices manufacturer is poised for growth. ...
  42. Johnson And Johnson Resilient Despite Recalls

    October 22, 2010
    Despite a bad quarter for Johnson and Johnson, the actual results show the competitive advantages of this company.
  43. Abbott Labs Showing Meaningful Growth

    October 21, 2010
    Abbott might just be the best healthcare stock today.
  44. St. Jude Is Fine Today But What About Tomorrow?

    October 21, 2010
    St. Jude is holding its own, but investors will demand more if the stock is to outperform.
  45. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  46. Johnson & Johnson Needs A Catalyst

    July 22, 2010
    It's difficult to find a catalyst for growth to return to more historical levels at Johnson & Johnson.
  47. Is Market Correction Creating Opportunity?

    July 5, 2010
    The stock market correction is grinding on and has moved some stocks to below levels reached when the market hit bottom in ...
  48. Covidien Shuffles The Deck

    June 1, 2010
    Covidien made a surprising deal to get into peripheral vascular therapies - a business with big growth potential.
  49. Intuitive Surgical - Are Robots To Be Trusted?

    June 1, 2010
    Can Intuitive Surgical produce the growth necessary to validate the stock's lofty perch?
  50. Great Dividend Payers In Medical Technology

    May 21, 2010
    Dividend-paying stocks are not common in medical technology, but these four proven winners deliver the goods.
  51. 5 Reasons To Love Greenlight Capital Re

    March 11, 2010
    David Einhorn, noted investor, is Chairman and largest shareholder of this Cayman Island reinsurance company.
  52. Executive Bonuses Must Go

    December 3, 2009
    Professor Henry Mintzberg wrote an article about why executive bonuses must go. We look at the Forbes' CEO compensation list ...
  53. Medtronic's Mixed Medical Bag

    February 24, 2009
    Medtronic stock offers potential gains - if it can survive the competition.
  54. Who's Really Winning The Heart-Stent Race?

    May 14, 2008
    All the stent makers claim they're the sole industry leader. We help cut through the clutter.
  55. Abbott Labs Finally Turns Potential Into Profit

    April 17, 2008
    Solid numbers for the last two quarters could change Abbott Labs's reputation as an overvalued stock.
  56. Boston Scientific Shaken, But Not Stirred (BSX)

    November 8, 2006
    Boston Scientific looks poised for higher per share valuations in the future.
Trading Center